| Dr. K G Raghu |
Fukugiside from Garcinia travancorica is a promising lead for non-alcoholic fatty liver disease by activation of PPARα expression and up-regulation of AMPK. |
| Sujata Sharma |
|
| Dr. Abhijit Anil Trailokya |
“Confidence Trial – Subgroup analysis” |
| Vishal Ambekar |
A STUDY OF PREVALENCE AND PROGNOSIS OF URINARY TRACT
INFECTIONS IN TYPE 2 DIABETIC PATIENTS -AT TERTIARY CARE HOSPITAL
|
| Dr.P.Anand |
Comparative study on the prevalence of hepatic fibrosis among type 2 diabetics with non diabetic subjects |
| Dr.Surbhi Khatod |
POSSIBILITY OF ORAL GLUCOSE TOLERANCE TEST CLEARANCE IN TYPE 2 DIABETES PATIENTS WHO UNDERWENT COMPLETE DIABETES REMISSION |
| Dr. Soumyaranjan Mohanty |
OBSERVATIONAL STUDY ON DAPAGLIFLOZIN AND HYPERTENSION |
| Vaibhav Rathi |
ADDISONIAN CRISIS: A CASE REPORT |
| Dr. Pournima Kulkarni |
IMPROVEMENT IN ANXIETY AND DEPRESSION IN PATIENTS WITH TYPE 2 DIABETES THROUGH CUSTOMIZED LIFESTYLE INTERVENTION |
| "Dr.Mahima Nikalje |
TO ANALYZE LIPID GOALS IN OPD PATIENTS OF ASCVD (SECONDARY PREVENTION) IN A TERTIARY CARE HOSPITAL |
| Sthuti Choudhary |
ASSESSMENT OF DIET DIVERSITY AMONG WORKING WOMEN IN MUMBAI AND ITS
ASSOCIATION WITH DIABETES RISK AS DETERMINED BY THE INDIAN DIABETES
RISK SCORE (IDRS): A CROSS SECTIONAL STUDY" |
| Dr Muskaan |
A case study on autoimmune hepatitis in middle aged female- a rare cause of chronic liver disease in India |
| Ms. Niyati Tandon |
PREVALENCE OF SARCOPENIA IN INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS AGED 40 - 60 YEARS IN BENGALURU. |
| Dr. Abha Khisty |
COGNIREHAB: THE GOOD OLD EXERCISES AND REFURBISHED TRANSCRANIAL DIRECT CURRENT STIMULATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT IN TYPE 2 DIABETES MELLITUS(T2DM) |
| Mr. NEERAJ KUMAR |
EFFICACY AND SAFETY OF A FIXED-DOSE COMBINATION OF VILDAGLIPTIN AND PIOGLITAZONE IN INDIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A RANDOMIZED, OPEN LABEL, COMPARATIVE, PHASE III STUDY |
| Miss Shruti Kejriwal |
READY TO COOK FLOUR: ACCEPTABILITY AND EVALUATION FOR A PRE-DIABETIC, DIABETIC. |
| Dr. Pramod Joshi |
A CROSS SECTIONAL STUDY ON DEMOGRAPHICS OF PEOPLE WITH HYPERTENSION AND USAGE PATTERNS OF ANTI-HYPERTENSIVE AGENTS AMONG INDIAN PHYSICIANS |
| Dr. Navya Antony |
A CLINICAL TRIAL TO EVALUATE EFFICACY AND SAFETY OF VILDAGLIPTIN SR + DAPAGLIFLOZIN IN TYPE2 DIABETES MELLITUS |
| Mrs. Anu Mahajan |
ASSESSMENT OF QUALITY OF LIFE (QOL) ACROSS GENDER AMONG SUBJECTS WITH T2DM USING MODIFIED DIABETES QUALITY OF LIFE QUESTIONNAIRE. |
| Prof. Ruchu Kuthiala |
IMPACT OF NUTRACEUTICALS IN MITIGATING METABOLIC SYNDROME: PERSPECTIVE OF HEALTH PRACTITIONERS |
| Dr. Sona Warrier |
PATIENT PROFILING AND OUTCOME ASSESSMENT OF VILDAGLIPTIN AND DAPAGLIFLOZIN FIXED DOSE COMBINATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS - A REAL-WORLD RETROSPECTIVE STUDY IN INDIA |
| Dr. Priyanka Joshi |
ASSESSING THE EFFICACY AND SAFETY OF FIXED DOSE COMBINATION OF DAPAGLIFLOZIN AND SITAGLIPTIN IN INDIAN POPULATION: A REAL-WORLD RETROSPECTIVE STUDY (REAL DAPSI) |
| Dr. TRIPTI SHARMA |
REAL-WORLD EXPERIENCE OF LOW DOSE GLIMEPIRIDE (0.5 MG) AND METFORMIN (500MG) FIXED DOSE COMBINATION IN NEPALESE TYPE 2 DIABETES MELLITUS PATIENTS |
| Dr. INDRASHISH MUKHERJEE |
"CLINICAL SIGNIFICANCE & NBSP;OF CIRCULATING SECRETED FRIZZLED- RELATED PROTEIN 5 (SFRP5) AND WINGLESS- TYPE MMTV INTEGRATION SITE FAMILY MEMBER 5A (WNT5A) LEVELS IN PREDIABETIC PATIENTS IN A TERTIARY CARE CENTRE |
| Afreen Ariff Sait |
Lipid-Lowering and Free radical Scavenging Activity of Methanolic extracts of Ocimum tenuiflorum and Curcuma longa on HepG2 cell line under Glucotoxic and Lipotoxic Conditions |
